You are here:
Publication details
Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018
Authors | |
---|---|
Year of publication | 2018 |
Type | Conference abstract |
Citation |